Fiera Capital (Canada)’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,080,099
Closed -$32.6M 416
2026
Q1
$32.6M Buy
1,080,099
+35,268
+3% +$1.14M 0.11% 151
2025
Q4
$36.3M Buy
1,044,831
+249,674
+31% +$8.81M 0.12% 146
2025
Q3
$28.9M Sell
795,157
-17,917
-2% -$609K 0.09% 144
2025
Q2
$25.5M Buy
813,074
+7,924
+1% +$246K 0.09% 142
2025
Q1
$23.9M Buy
805,150
+25,186
+3% +$756K 0.09% 141
2024
Q4
$23M Sell
779,964
-65,768
-8% -$2.08M 0.07% 144
2024
Q3
$26.3M Sell
845,732
-29,861
-3% -$1.09M 0.08% 138
2024
Q2
$29.7M Buy
875,593
+9,181
+1% +$468K 0.09% 133
2024
Q1
$56.3M Buy
866,412
+19,625
+2% +$1.35M 0.16% 90
2023
Q4
$57.9M Buy
846,787
+166,988
+25% +$8.68M 0.18% 83
2023
Q3
$35.3M Buy
679,799
+158,502
+30% +$9.38M 0.11% 110
2023
Q2
$31.3M Buy
+521,297
New +$29.8M 0.09% 124

Other funds holding IMCR

Fiera Capital (Canada)'s IMCR Position: Q2 2026 in Review

Fiera Capital (Canada) sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 1,080,099 shares — an estimated $32.6M sold.

Fiera Capital (Canada) first reported a position in IMCR in Q2 2023 and held it in 12 quarters. The position peaked at $57.9M in Q4 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Fiera Capital (Canada) reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,080,099 Immunocore shares in Q2 2026, an estimated $32.6M.
  • Fiera Capital (Canada) first reported a position in Immunocore in Q2 2023 and held it in 12 quarters.
  • Fiera Capital (Canada)'s Immunocore position peaked at $57.9M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.